FREE Account Opening + No Clearing Fees
Loading...

Zydus Lifesciences Buyback Latest News Today

Zydus Lifesciences Buyback Detail
Buyback Record Date June 2, 2022
Buyback Open Date June 23, 2022
Buyback Closing Date July 6, 2022
Issue Size (Shares) 1.15 Crores
Issue Size (Amount) ₹750.00 Crores
Buyback Price ₹650 per Share
  1. Delhi HC reinstates injunction on Zydus, halting sale of breast cancer drug Sigrima

    October 18, 2024 9:45:00 PM

    In another significant setback for Indian pharma company Zydus Lifesciences, the Division Bench of the Delhi High Court (HC), on October 16, 2024, reinstated the injunction preventing Zydus from ...

    Published by : Pharmabiz
  2. Zydus Lifesciences shares jump 5% from intraday low to hit record high; heres why

    July 10, 2024 3:29:00 PM

    Shares of Zydus Lifesciences Ltd on Wednesday staged a sharp upmove during late deals. The stock recovered 4.98 per cent from an intraday low price of Rs 1,133.55 to hit an all-time high of Rs 1,190.

    Published by : MSN
  3. Zydus Lifesciences Ltd (ZYDUSLIFE) Share Price

    October 22, 2024 3:30:00 AM

    Zydus Lifesciences Ltd share price was down by -3.60% from the previous closing price of ?1,058.15. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...

    Published by : Business Today
  4. Zydus Lifesciences

    March 7, 2022 8:51:00 AM

    Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1268 in its research report dated October 03, 2024. Zydus Lifesciences, Maruti Suzuki ...

    Published by : moneycontrol.com
  5. Zydus Life gets USFDA approval for Fludrocortisone Acetate tablets; shares trade flat

    October 18, 2024 11:24:00 AM

    Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg from the United States Food and Drug ...

    Published by : moneycontrol.com
  6. Zydus Lifesciences gets USFDA nod for prostate cancer drug

    October 3, 2024 4:41:00 PM

    On Wednesday, Zydus Lifesciences said that the US health regulator has given the company permission to develop a generic medication for the treatment of prostate cancer. The product would be ...

    Published by : India Infoline
  7. Zydus Lifesciences acquires UK-based LiqMeds Group for GBP 68 million

    October 31, 2023 2:00:00 PM

    New Delhi, Zydus Lifesciences on Tuesday said it has acquired UK-based LiqMeds Group for GBP 68 million (around Rs 689 crore). The Ahmedabad-based group, through its wholly-owned subsidiary Zydus ...

    Published by : Business Insider India
  8. ZYDUS LIFESCIENCES LTD

    July 11, 2022 6:09:00 PM

    Zydus said Desidustat, sold under the Oxemia trademark, is a prescription drug approved in India for patients with CKD induced anemia, and can be taken only under the advice and guidance of a ...

    Published by : health.economictimes.indiatimes
  9. Zydus Lifesciences share price

    September 30, 2024 3:30:00 AM

    Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the ...

    Published by : Mint
  10. ZYDUS LIFESCIENCES

    February 24, 2022 4:08:00 PM

    The US Food and Drug Administration (USFDA) conducted inspection at the injectables manufacturing facility between April 15 and April 23, 2024, Zydus Lifesciences said in a regulatory filing.

    Published by : health.economictimes.indiatimes

Read Zydus Lifesciences Buyback current news. Find Zydus Lifesciences Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Zydus Lifesciences Limited Buyback grey market premium and Zydus Lifesciences Buyback expected listing price.